Melanotan I (Afamelanotide)
α-MSH analog · approved for erythropoietic protoporphyria
Overview
Melanotan I (Afamelanotide) is a synthetic α-MSH analog and MC1R agonist studied in pigmentation and photoprotection. Approved in several jurisdictions as a prescription drug for erythropoietic protoporphyria.
Specifications
- CAS
- 75921-69-6
- Purity (HPLC)
- ≥ 99.0%
- Common vial sizes
- 10 mg
- MOQ
- On request
- Lead time
- 10–18 days
- Storage
- -20°C, protect from light
Documentation available on request
- Certificate of Analysis (COA)
- HPLC Chromatogram
- Mass-spec spectrum
- Stability data
- SDS / MSDS
- Sequence verification
Regulatory note
Approved as a prescription drug in several jurisdictions. Sold only to qualified buyers with appropriate licensing in their jurisdiction.
Related peptides